<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04365140</url>
  </required_header>
  <id_info>
    <org_study_id>ACDm126</org_study_id>
    <nct_id>NCT04365140</nct_id>
  </id_info>
  <brief_title>MicroRNA-126 and Its Target VCAM-1Dermatitis to Nickel</brief_title>
  <official_title>Alteration of the microRNA-126 Expression: a Possible Mechanism in Allergic Contact Dermatitis to Nickel</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de San Luis Potosí</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Autonoma de San Luis Potosí</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background. Allergic Contact Dermatitis (ACD) is an inflammatory skin disease mediated by
      direct contact with allergens as nickel, the most common allergen, that may be related with
      epigenetic changes.

      Objective. Evaluate the miR-126 expression and its target VCAM-1, in the skin of patients
      with ACD to nickel.

      Methods. Fifteen patients with positive patch test to nickel were included, and the
      expression of miR-126 and VCAM-1 was evaluated by RT-qPCR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients that went to the dermatology and outpatient department of the Central Hospital &quot;Dr.
      Ignacio Morones Prieto &quot;, with a suspected diagnosis of nickel allergic contact dermatitis,
      were invited to participate in this study. Later, the objective and methodology of the study
      were explained to them, as well as the advantages of participating and the possible
      undesirable effects. All patients signed the informed consent previous perfom the medical
      history. After, the epicutaneous patch test was performed, and patients were divided
      according to the result them. Finally, under local anesthesia, two 3-mm punch biopsies, from
      lesional (positive parch test site) and adjacent non lesional skin, 10 cm apart, were
      performed. Tissues for reverse transcriptase real-time polymerase chain reaction (RT-qPCR)
      analyses were stored frozen in sterile tubes at 80ºC until processing
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>Expression of miR-126</measure>
    <time_frame>9 months</time_frame>
    <description>Relative expression of the miR-126 on skin biopsies from ACD patients</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Allergic Contact Dermatitis</condition>
  <arm_group>
    <arm_group_label>positive ACD to nickel</arm_group_label>
    <description>Patients with positive epicutaneous patch test to nickel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>negative ACD to nickel</arm_group_label>
    <description>Patients with negative epicutaneous patch test to nickel</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      skin biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Female and male patients with allergic contact dermatitis for more than one year
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age and older

          -  Epicutaneous Patch Test positive to Nickel

          -  without previous treatment within the previous 4 weeks

        Exclusion Criteria:

          -  Pregnancy

          -  nursing

          -  menopause

          -  consumption of any type of drugs (including anti-inflammatories and hormonal
             treatments) within the previous 2 months

          -  coexistence of other dermatoses conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan P Castanedo-Cazares, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dermatology Department. Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dermatology Department. Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</name>
      <address>
        <city>San Luis Potosí</city>
        <zip>78210</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Martins LE, Reis VM. Immunopathology of allergic contact dermatitis. An Bras Dermatol. 2011 May-Jun;86(3):419-33. English, Portuguese.</citation>
    <PMID>21738956</PMID>
  </reference>
  <reference>
    <citation>Ahlström MG, Thyssen JP, Wennervaldt M, Menné T, Johansen JD. Nickel allergy and allergic contact dermatitis: A clinical review of immunology, epidemiology, exposure, and treatment. Contact Dermatitis. 2019 Oct;81(4):227-241. doi: 10.1111/cod.13327. Epub 2019 Jul 9. Review.</citation>
    <PMID>31140194</PMID>
  </reference>
  <reference>
    <citation>Cerutti C, Edwards LJ, de Vries HE, Sharrack B, Male DK, Romero IA. MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium. Sci Rep. 2017 Mar 30;7:45284. doi: 10.1038/srep45284.</citation>
    <PMID>28358058</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 23, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Autonoma de San Luis Potosí</investigator_affiliation>
    <investigator_full_name>Juan Pablo Castanedo-Cazares</investigator_full_name>
    <investigator_title>Adjunt professor</investigator_title>
  </responsible_party>
  <keyword>allergic contact dermatitis</keyword>
  <keyword>nickel</keyword>
  <keyword>microRNAs</keyword>
  <keyword>VCAM-1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Contact</mesh_term>
    <mesh_term>Dermatitis, Allergic Contact</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

